Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals ALNY
$ 244.67 -0.87%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Alnylam Pharmaceuticals EV/EBITDA Ratio 2011-2024 | ALNY

Annual EV/EBITDA Ratio Alnylam Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-31.5 -22.5 -13.6 -9.69 -23.2 -7.6 -20.3 -40 -63.3 -21 -8.11

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-7.6 -63.3 -23.7